Aphria Inc. (NYSE:APHA)’s earnings report is expected by WallStreet on April, 15, as reported by RTT. Analysts forecast 166.67 % diference or $-0.04 from the $0.06 EPS from 2018. Wall Street now forecasts 300.00 % negative EPS growth despite Aphria Inc. last quarter’s EPS of $-0.01. Ticker’s shares touched $10 during the last trading session after 0.79% change.Currently Aphria Inc. is downtrending after 4.67% change in last April 9, 2018. APHA has also 2.67M shares volume. APHA underperformed the S&P 500 by 9.04%.
Aphria Inc. produces and sells medical cannabis in Canada and internationally.The firm is valued at $2.50 billion. The firm offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils.33.44 is the P/E ratio. It serves patients and health professionals.